Strata Critical Medical (NASDAQ:SRTA – Get Free Report) CEO William Heyburn sold 31,671 shares of the firm’s stock in a transaction on Monday, June 8th. The stock was sold at an average price of $5.87, for a total transaction of $185,908.77. Following the sale, the chief executive officer owned 1,548,997 shares in the company, valued at approximately $9,092,612.39. The trade was a 2.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Strata Critical Medical Stock Performance
Shares of NASDAQ:SRTA traded down $0.12 during midday trading on Wednesday, reaching $5.49. 1,306,162 shares of the company were exchanged, compared to its average volume of 874,584. Strata Critical Medical has a fifty-two week low of $3.57 and a fifty-two week high of $6.50. The stock’s fifty day moving average price is $5.14. The firm has a market cap of $475.05 million, a price-to-earnings ratio of -68.63 and a beta of 2.20.
Strata Critical Medical (NASDAQ:SRTA – Get Free Report) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.03 EPS for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.07. Strata Critical Medical had a net margin of 20.56% and a negative return on equity of 4.06%. The business had revenue of $67.38 million for the quarter. As a group, analysts expect that Strata Critical Medical will post -0.14 earnings per share for the current year.
Analyst Upgrades and Downgrades
Get Our Latest Stock Report on SRTA
Institutional Inflows and Outflows
Institutional investors have recently modified their holdings of the company. Bank of America Corp DE increased its stake in shares of Strata Critical Medical by 16.2% during the 1st quarter. Bank of America Corp DE now owns 181,574 shares of the company’s stock worth $759,000 after purchasing an additional 25,379 shares during the last quarter. Quantinno Capital Management LP increased its stake in shares of Strata Critical Medical by 98.7% during the 1st quarter. Quantinno Capital Management LP now owns 143,239 shares of the company’s stock worth $599,000 after purchasing an additional 71,155 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in shares of Strata Critical Medical by 11.9% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,617,104 shares of the company’s stock worth $6,759,000 after purchasing an additional 172,154 shares during the last quarter. Principal Financial Group Inc. bought a new stake in shares of Strata Critical Medical during the 1st quarter worth about $537,000. Finally, Seelaus Asset Management LLC boosted its holdings in shares of Strata Critical Medical by 32.7% during the 1st quarter. Seelaus Asset Management LLC now owns 24,350 shares of the company’s stock worth $102,000 after buying an additional 6,000 shares during the period. 47.36% of the stock is currently owned by institutional investors and hedge funds.
About Strata Critical Medical
Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.
Featured Stories
- Five stocks we like better than Strata Critical Medical
- Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
- This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
- Intel Is the Market’s Most Mispriced AI Hedge
- The Biggest Opportunity From SpaceX’s IPO May Surprise You
Receive News & Ratings for Strata Critical Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Critical Medical and related companies with MarketBeat.com's FREE daily email newsletter.
